| Literature DB >> 31109591 |
Zhenya Tang1, Guilin Tang2, Shimin Hu2, Keyur P Patel2, C Cameron Yin2, Wei Wang2, Pei Lin2, Gokce A Toruner2, Chi Y Ok2, Jun Gu3, Xinyan Lu4, Joseph D Khoury2, L Jeffrey Medeiros2.
Abstract
MECOM rearrangement is associated with rapid disease progression and poor prognosis in myeloid neoplasms. Previous studies were often based on 3q26.2 abnormalities without confirmation of MECOM status. The frequency of MECOM rearrangement and attribution of various chromosomal aberrations remain poorly characterized. This study presented 129 cases with confirmed MECOM rearrangement by karyotyping and multiple FISH methodologies. MECOM rearrangement arose through translocation (49.6%, n = 64), inversion (40.3%, n = 52), insertion (5.4%, n = 7) or unknown mechanism(s) (4.7%, n = 6). The classic inv(3)(q21q26.2) was dominant (n = 50) in inversion-driven MECOM rearrangement; and 3 of them also had double inv(3). For translocation-driven MECOM rearrangement, t(3;21) was most common (n = 15), followed by t(2;3) (n = 13), t(3;12) (n = 10), t(3;3) (n = 9), t(3;8) (n = 6), t(3;6) and t(3;17) (n = 4 each), t(1;3) and t(3;?) (n = 1 each). Cases with t(3;3)-, t(3;12)-, and insertion-driven MECOM rearrangement were prone to exhibit a complex karyotype, while cases with t(2;3)-, t(3;21)- and insertion-driven MECOM rearrangement were prone to have an "unbalanced" MECOM FISH signal pattern, likely caused by uncommon breakpoint(s) within the target of 5'MECOM probe. Therefore, atypical chromosomal aberrations and/or mechanisms are involved in MECOM rearrangement. Confirmation/exclusion of MECOM rearrangement is necessary in all cases with a 3q26.2 abnormality. (Word count: 190).Entities:
Keywords: Fluorescence in situ hybridization (FISH); Karyotyping; MECOM rearrangement; Map-back; Myeloid neoplasms; aCGH
Mesh:
Substances:
Year: 2019 PMID: 31109591 DOI: 10.1016/j.cancergen.2019.03.002
Source DB: PubMed Journal: Cancer Genet